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Alkaline phosphatase (APase) hydrolyzes phosphate esters
at an alkaline pH. For this study APase was extracted from
the thymic lymphoma and placental tissue of sixteen day
pregnant C57BL mice. In an effort to determine the function
of APase the hydrolysis of substrates pNPP and CASP by APase
was compared biochemically. The tested parameters demon¬
strated that APase extracted from the thymic lymphoma
hydrolyzed CASP with a similar biochemical characterization
to the hydrolysis of pNPP. However pNPP was hydrolyzed at
approximately three times the rate of CASP hydrolysis.
iii
The results in this study are conflicting with Neumann
et al., 1974. They isolated an APase from the thymic
lymphoma of C57BL mice which did not hydrolyze CASP while it
did hydrolyze pNPP. The reason for this contrast in data is
unknown since the method used for the assay of CASP
hydrolysis was that used by Neumann. Due to the consistent
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Alkaline phosphatase (APase) hydrolyzes phosphate esters
at an alkaline pH. Although this enzyme has been associated
with murine thymic lymphomas for some period of time (Smith,
1961, 1962; Metcalf et al., 1962; De-The, 1966; Haran-Ghera
et al., 1967; Lagerlbf and Kaplan, 1967; Siegler and Rich,
1967; Lumb and Doell, 1970 and Wilson et al., 1972) its
function is still unknown. The C57BL strain of mice was
chosen as a system of study since this strain has a low in¬
cidence of spontaneous lymphoma, but a high incidence of
lymphoma induced by urethan or other chemical carcinogens.
Neumann et al. (1970, 1971, 1974, 1976), Wilson et al.
(1971), Haran-Ghera et al. (1972), and Moran et al. (1973)
have done extensive studies on the hydrolysis of cysteamine-
s-phosphate (CASP) and para-nitrophenyl phosphate (pNPP) by
APase extracted from murine and human cell lines. They iso¬
lated a distinct APase showing unique catalytic properties
which they named N-alkaline phosphatase (N-APase). In the
instance of lymphoproliferative diseases of the murine and
human system N-APase did not hydrolyze CASP (Neumann et al.,
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1970, 1971, 1974, 1976; Moran at al., 1973). However, our
results are contradictory to these findings since GASP was
hydrolyzed by APase extracted from normal and lymphoma murine
tissues. Thus, it is the objective of this work to charac¬
terize the activity toward GASP and pNPP to determine if
these substrates are hydrolyzed by the same enzyme. A com¬
parison of the hydrolysis of these two substrates employing
crude extracts of lymphoma and normal placental tissue was
made using the parameters of pH, activation, inhibition,
heat inactivation, and kinetics. Substrate specificity
assays were also performed on purified enzyme extracts.
CHAPTER II
REVIEW OF LITERATURE
The Murine Leukemia Virus
Gross (1951, 1958) first established that a subcellular
agent was involved in the induction of murine thymic lymphoma.
Haran-Ghera (1967) demonstrated the induction of murine tumors
by using cell free extracts from tumors previously induced by
chemical agents. Therefore, these tumors were actually induced
by a subcellular agent, presumably a virus.
Furthermore, Kaplan (1964) postulated that a transmis¬
sible agent was present during post-natal life in normal C57BL
mice and that irradiation altered the sites of storage of the
latent agent which resulted in its release. The effect of
urethane (ethyl carbamate) could be thymic injury and regen¬
eration of immature lymphocytes which are more susceptible to
neoplastic transformation (Kaplan, 1961). This causative
agent was further understood when De-The (1966) substantiated
that the murine capsule agent is made up of two parts, the
nucleocapsid and the envelope. He stated that viruses mature
by a budding process through the plasma membrane of the host
cells. The viral envelope derives from the cell host membrane.
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By experiments consisting of injecting the Moloney leukemia
virus into the murine system, he noted that alkaline phospha¬
tase (APase) was associated with the envelope of the virus.
Since the origin of APase appeared to be the APase positive
leukemia cells, De-The (1966) concluded that APase repre¬
sented a marker to trace the portion of virions produced by
the leukemic lymphoblasts.
Once it was substantiated that APase associates with the
viral envelope and therefore the host membrane, a thorough
analysis was undertaken of both the leukemia virus and APase.
Bernard (1960) and Dmochowski (1960) noted that the
murine leukemia virus appears as a C-type particle under the
electron microscope. The C-type particles are spheres ap¬
proximately 100 nanometers in diameter and are limited by a
single or double outer membrane.
By biochemical analysis, Quigley et al. (1972) estab¬
lished that the viral envelope contained large amounts of
lipid in addition to protein. This accounts for their sensi¬
tivity to phospho-lipase and lipid solvents.
Association of Alkaline Phosphatase with Murine Leukemia
By histochemical techniques. Smith (1961) showed that
the cortex of the normal thymus of the AKR strain of mice
demonstrated APase activity. However, of the thymic cortical
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cells of the C57BL strain of mice showed no evidence of APase
activity. After injection of a carcinogen, the normally nega¬
tive cortical area became positive. The strength of
reactivity increased with time of exposure to radiation.
Although the thymus is the target organ for leukemic
cells, Haran-Ghera et al. (1967) demonstrated that 7,12-
dimethylbenz(a)anthracene(DMBA)-induced lymphatic leukemias
did not depend upon the thymus for development. She reported
a 60 percent incidence of lymphosarcomas and 27 percent
myeloid leukemia in thymectomized mice.
A possible reason for these variable incidences among
different types of leukemias was postulated by Haran-Ghera
(1972). They noted that virus-induced tumors appeared to have
a lower level of APase activity than DMBA-induced leukemias
with or without a thymus. They reasoned that this could be
due to the fact that carcinogen-induced lymphatic leukemias
involve transformation of B-lymphocytes while spontaneous and
virus-induced leukemias are T-cell leukemias.
Histochemical localization of APase was demonstrated on
the membrane of lymphoma cells (Lumb and Doell, 1970). In the
normal spleen APase is localized in cells surrounding the
germinal follicles. In the thymus of the 16 day fetus, APase
appeared in large mitotically active cells presumed to be the
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precursor of thymic lymphocytes (Lagerlof and Kaplan, 1967;
Lumb and Doell, 1970). APase was not found in thymic lympho¬
cytes of normal C57BL adult mice.
Several theories have developed as to the mechanism of
APase elevation. Siegler and Rich (1967) claimed that an
elevation in APase activity occurred only after lymphoma cells
proliferated and the thymus enlarged to at least three times
its original size in wet weight.
By using a more sensitive histochemical technique,
Lagerlof and Kaplan (1967) obtained results contradictory to
the observations of Siegler and Rich (1967). Lagerlof and
Kaplan showed that the development of APase activity in the
murine system was a specific response induced concomitantly
with neoplastic transformation. However, Siegler and Rich
(1967) claimed that an elevation in APase activity occurred
only after lymphoma cells proliferated and the thymus enlarged
to at least three times its original size in weight. Since
they used a less sensitive histochemical method than did
Lagerlof and Kaplan (1967) it is assumed that Siegler and Rich
(1967) reached an erroneous conclusion. Lagerlof and Kaplan
(1967) theorized that APase activity did not seem to be merely
an expression of cell immaturity since it disappeared from the
fetal thymus long before the cells matured.
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Lumb and Doell (1970) discovered a single electrophoretic
species with the same mobility in both the normal and lympho-
maceous spleen. They therefore postulated that APase elevation
was a result of derepression of cell-coded enzyme during neo¬
plastic transformation.
In order to understand APase it is necessary to have a
general knowledge of enzyme patterns. Enzyme differentiation
is a process whereby the development of an organ acquires adult
enzyme patterns (Criss, 1971). A question to be considered is
whether neoplastic tissues have a distinctive and unique enzyme
pattern just as normal organ systems do. Neoplastic tissues
have lost many of their differentiated functions. This loss of
function could be attributed to the loss of an enzyme. How¬
ever, loss of an enzyme or an increase or decrease in enzyme
activity may or may not be indicative of loss of a specific
pathway. Criss (1971) reported that fetal tissues are not
subject to the same extra- and intracellular controls as the
corresponding normal adult tissues. In tumor tissues, enzyme
patterns may vary within different tumor tissues in the same
animal species. A control which is altered in tumor cells is
increased cell growth and division.
Biochemical Characterization of Murine Alkaline Phosphatase
According to Lumb and Doell (1970) preliminary biochemical
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characterization of APase activity in thymus tissue of normal
16 day fetuses is consistent with the APase activity of the
tumor and nomal spleen. Disc-gel electrophoresis performed
on the normal C57BL adult mice and tumor tissue extracts from
this same strain showed isozyme patterns of which the major
component of the tumor APase had mobility similar to the normal
spleen. The minor component of tumor APase had a slower mobil¬
ity than any component of the enzyme extracted from normal
tissue. According to the pH optimum and heat inactivation,
the liver and duodenum APases were distinct from tumor, spleen
and the fetal thymus APase activity.
Preincubation of mouse ovarian APase in the presence of
EDTA and glycine at an alkaline pH resulted in inactivation of
APase activity (Bramley, 1975). Inactivation did not occur
upon preincubation with EDTA or glycine alone. Inactivation
involved the formation of an enzyme-metal ion-amino acid
complex. This complex probably decayed in a time-dependent
manner to a form that was rapidly attacked by EDTA.
According to the purification procedure performed by
Davis (1976), there was a yield of 26 percent placental APase
from C57BL mice with a 600-fold purification. It was concluded
by SDS acrylamide gel electrophoresis and G-200 Sephadex
chromatography that the purified APase had an active monomer
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of 60,000 M.W. This monomer was composed of two polypeptide
chains of equal molecular weight.
Substrate Specificity
In an extensive review, Fishman (1974) noted that two
basic reactions are catalyzed by APase: 1) cleavage of P-O-C
bonds, and 2) phosphotransferase activities. APase also
cleaves P-F, P-O-P, P-S, and P-N bonds. The phosphotransfer¬
ase reactions require as acceptor molecules R-OH (R=H or alkyl
group). An example of substrates possessing a P-0 bond and a
P-S bond are para-nitrophenyl phosphate and cysteamine-S-phos¬
phate, respectively. A comparison of the hydrolysis of these
two substrates was undertaken in previous communications by
extracting APase from Escherichia coli. Neumann et al. (1967)
and Neumann (1968) determined that the point of cleavage for
GASP was the P-S bond which is analogous to the P-0 cleavage
of pNPP. The kinetic behavior of GASP hydrolysis by APase
from coli proved to be very similar to the enzymic hydroly¬
sis of pNPP (Neumann et al. , 1967 and Neumann, 1968). Both
reactions had a similar pH maximum, similar MgCl2 activation,
the same dependence on salt concentrations, and very similar
kinetic constants: Km=9.5 X 10~^M for the hydrolysis of pNPP
and Km=9.4 X 10“^M for GASP hydrolysis. Neumann et al. (1967)
determined that GASP competitively inhibited the hydrolysis
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of pNPP. Therefore, they suggested that GASP and pNPP were
bound to the same catalytic site of APase from the coli
system.
Neumann (1968) discovered that APase from coli cata¬
lyzed the synthesis of monophosphate esters of serine,
ethanolamine, propanol amine, butanol, glycerol, L-glucose,
and tris (hydroxy methyl) amino methane by phosphoryl trans¬
fer from GASP (donor) to the respective alcohols (acceptors).
These same compounds were phosphorylated to essentially the
same extent when the donor was pNPP.
Neumann et al. (1971) noted that the most significant
difference between APases derived from murine leukemic and
nonleukemic tissues was the rate of hydrolysis of monoesters
of orthophosphoric acid (pNPP) and S-substituted monoesters of
thiophosphoric acid (GASP). In leukemic tissue her results
indicated a higher rate of pNPP hydrolysis and virtually no
APase activity towards GASP. Therefore, the ratio of pNPP to
GASP hydrolysis in leukemic tissue was greater than the ratio
in nonleukemic tissue. Neumann et al. (1976) observed that
APase from a Burkitt lymphoma human cell line and Moloney
virus-induced murine leukemia did not hydrolyze GASP or hydro¬
lyzed it to a negligible extent. They postulated that these
differences in hydrolysis rates could be due to a fundamental
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change in enzymes in diseased tissues, to unknoxm factors
which change kinetic parameters, or to the presence of two or
more different types of APase.
Neumann et al. (1971) felt that the later postulation was
the most likely since they identified a different type of APase
derived from lymphoblastoid human and murine lines. They
called this enzyme N-APase. The identification of APase was
based upon (Neumann et al. 1976) the ratio of hydrolysis of
pNPP versus GASP under identical conditions and a different
electrophoretic mobility from that of normal lymphocyte APase.
In studies previous to 1976, Neumann et al. observed that
the rates of hydrolysis of pNPP and GASP by APase extracted
from the organs of normal mice and sera of normal humans were
very similar. The ratio of pNPP/GASP activity in normal tissue
sera did not exceed 1.9. The APase activities of normal and
mitogen-stimulated lymphocytes of human, murine, or porcine
origin migrated identically electrophoretically (Neumann et al.
1976). They considered the lack in differences of APase activ¬
ity derived from normal specimens toward substrates pNPP and
GASP to be an important factor in determining the mechanism of
APase. The similar hydrolysis of the linking oxygen and
sulfur bonds was not expected by Neumann et al., since oxygen




Neumann et al. (1971, 1976) isolated a distinct APase
isoenzyme N-phosphatase (N-APase) which had a unique substrate
specificity and electrophoretic mobility. Fast moving bands
were obtained from murine lymphoma cells and human lympho-
blastoid cell lines when compared with APase activity present
in normal lymphocytes. This isoenzyme accumulated in the
serum and tissues of patients with acute and chronic lymphatic
leukemia, lymphosarcoma, and infectious mononucleosis (Neumann
et al., 1974). According to biochemical characterization
N-APase closely resembled the APase extracted from murine
lymphatic leukemia induced by the Gross virus. The level of
N-APase correlated with the clinical state of the patients.
Therefore, this enzyme could be used as a marker in all
patients with lympho-proliferative diseases.
Neumann et al. (1974) found that normal human serum
catalyzed the hydrolysis of both pNPP and GASP. However,
phosphatase-N (N-APase) found in murine lymphoma tissue and
serum from patients with leukemia did not hydrolyze GASP while
it did hydrolyze pNPP. Since normal APase and N-APase both
hydrolyzed pNPP, the hydrolysis represented the total serum
APase activity. In order to ascertain the level of N-APase
present, the amount of GASP hydrolyzed (split only by normal
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APase) was deducted from the amount of pNPP hydrolyzed.
Neumann et al. (1974) found that the level of N-APase
dropped with clinical improvement of the disease. They sug¬
gested that measurement of N-APase in the serum of patients
with lyrapho-proliferative diseases could be useful as a




Enzyme extracts were obtained from inbred C57BL/Ka mice.
These mice were originally obtained from Dr. Henry Kaplan of
Stanford University. They were maintained by brother-sister
mating. Thymic lymphomas were induced in these mice by
treatment with urethan or the endogenous virus of C57BL mice
(Lumb and Doell, 1970). All tumors were examined histologi¬
cally and only lymphoblastic lymphomas were used.
For most experiments, crude extracts were prepared by
mincing and pushing the tissue through a metal screen in
0.01 M tris buffer at pH 7.4 or grinding the tissue in a glass
homogenizer in this same buffer.
Enzyme Assays
The rate of hydrolysis of the substrates cysteamine-S-
phosphate (GASP) and para-nitrophenyl phosphate (pNPP) was
determined. The reaction mixtures contained 1.0 ml total vol¬
ume including the appropriate dilution of extract, distilled
water, 0.4 M diethanol amine (DEA) buffer with or without ap¬
propriate variables at a' pH of 10.0, and either pNPP
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(3.38 X 10~^M) or GASP (2.0 X 10”^M) was employed as substrates.
The absorbance at 400 nm was measured every 15 seconds for
4 minutes. The rate of enzymic hydrolysis was determined after
plotting the absorbance versus time. The amount of product
liberated per minute was calculated from the linear part of the
curve.
The rate of hydrolysis of GASP was determined from the
reaction of 5,5'-dithiobis (2-nitrobenzoic acid) (DTNB) with
cysteamine to yield 2-nitro-5-thiobenzoic acid. The DTNB did
not disturb the enzyme reaction and was therefore included in
the reaction mixture at 4 X 10“^M. Neumann et al. (1967) cal¬
culated molar absorptivity (E^qq = 13,600) at 412 nm. Assays
performed at 400 nm yielded the same results.
The rate of hydrolysis of pNPP was calculated assuming
E400 ~ 17,200 (Neumann et al., 1967).
pH Optimum
The pH optimum of APase with the appropriate substrate
was determined by varying the pH from 8.0 to 11.0.
Activation and Inhibition
Experiments were performed to determine the level of
activation by 5 mM magnesium chloride by comparing the
I
activities in the presence and absence of this activator.
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Inhibition by L-homoarginine and EDTA was determined by buf¬
fers containing magnesium. Percent inhibition was calculated
by comparison with the appropriate control.
Substrate Specificity
Substrates pNPP and GASP were used to determine specific¬
ity for tumors induced by urethan treatment or endogenous virus
of C57BL mice. These experiments were performed using 1.0 M
DEA with 5 mM magnesium chloride.
Heat Inactivation
The heat inactivation rate was determined by heating the
0.4 M DEA buffer containing magnesium plus extract for 0-10
minutes at 55 C. Substrate was then added and the tubes were
assayed. The rate was determined by Least Square Analysis of
the data expressed as the natural log of activity versus the
time incubated at 55 C.
Kinetic Studies
Kinetic experiments were performed by measuring the amount
of product liberated. The Michaelis-Menten Equation was trans-
■i
formed using the Lineweaver-Burke Plot. The reciprocal of the
velocity was plotted versus the reciprocal of substrate con¬




All data are reported as the mean and standard deviation
of at least three experiments. A student's t-test was per¬
formed for each parameter to determine significance.
CHAPTER IV
EXPERIMENTAL RESULTS
Figure 1 shows the effects of pH on the activation of
APase. The pH optimum of APase, utilizing the substrates
pNPP and GASP, was determined by varying the pH from 8.0 to
11.0. The highest level of APase activity for both substrates
was reached at a pH of 10.
Table 1 shows the results of experiments performed to
determine the level of activation by 5 mM MgCl2. The
activities in the presence and absence of this activator were
compared using crude extracts of placenta and lymphoma tissue.
APase activity in both of these tissues was activated by
magnesium by approximately the same rate.
Table 2 shows the inhibition of APase activities by
L-homoarginine utilizing pNPP and GASP. Inhibition was deter¬
mined by using buffers containing magnesium. Percent
inhibition was calculated by comparison with the appropriate
control. APase activities extracted from lymphoma tissue was
inhibited by approximately the same amount using both sub¬
strates .
Table 3 shows the results of inhibition experiments em¬
ploying EDTA and glycine. Percent inhibition was calculated
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Fig. 1. The pH optimum of alkaline phosphatase activities
utilizing para-nitrophenyl phosphate and
cysteamine-S-phosphate as substrate.
jjMp-nitrophenol/min/ml(—) —rv)OJ jjMcysteamine/min/ml()










Placenta pNPP 2.55 t 0.66 4.0 t 0.67 1.67 t 0.66
GASP 1.10 t 0.28 1.48 t 0.31 1.35 t 0.24
Lymphoma pNPP 0.40 t 0.02 0.77 t 0.10 1.91 t 0.30
GASP 0.24 t 0.07 0.39 ± 0.10 1.64 i: 0.29
^Mean and standard deviation determined for at least three experiments.
Activity expressed as micromoles product per minute per milliliters.
^Determined by activity in the present of 5mM magnesium chloride divided by
activity in the absence of magnesium chloride.
Table 2. Inhibition of Alkaline Phosphatase Activities by L-Homoarginine








Lymphoma- pNPP 0.64 t 0.25 0.12 t 0.03 79.47 t 7.04
GASP 0.34 t 0.18 0.06 t 0.02 70.26 t 13.14
Mean and standard deviation determined for at least three experiments.
Activity expressed as micromoles product per minute per milliliters.
^Determined by activity in the presence of homoarginine divided by activity
in the absence of homoarginine times 100.













Mean and standard deviation determined for at least three experiments.
Activity expressed as micromoles product per minute per milliliters.
^The activity assayed with EDTA and glycine was divided by the control (without
EDTA) times 100.
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by comparison with the appropriate control. A slight increase
in inhibition of APase activity was obtained when pNPP was
used as a substrate.
Table 4 shows how the substrates pNPP and GASP were used
to determine specificity for tumors present in the thymus,
spleen, and lymph nodes. These tumors were induced by urethan
treatment or endogenous virus of C57BL mice. For all of the
tumors pNPP hydrolysis was approximately 2.6 times the hydrol¬
ysis of GASP.
Figure 2 and Table 5 show that APase extracted from crude
lymphoma tissue proved to be heat labile. After four minutes
of incubation at 55 G, 63% of the enzymes activity was
destroyed when pNPP was the substrate, and there was 817o in¬
hibition at this same time period when GASP was the substrate.
The inactivation was complete at the end of eight minutes when
utilizing GASP. Inactivation was never complete using pNPP
within ten minutes incubation. According to the slopes ob¬
tained the inactivation rates employing both substrates did
not differ significantly at the 99% confidence limit.
Figure 3 shows the results of kinetic studies performed
by measuring the amount of product liberated utilizing pNPP
and GASP substrates. The Kra value determined for pNPP hy¬
drolysis was 5 X 10~^ M and 1 X 10“^ M for GASP. The maximal
Table 4. Substrate Specificity in Different Tumors
Activity^
Tumors^pNPP GASP pNPP/CASP
H416 0.154 + 0.02 0.66 t 0.01 2.38 + 0.46
H380 0.181 + 0.005 0.028t .004 2.94 + 0.75
H485 0.31
+
0.08 0.17 t 0.10 2.87 + 2.84
H462 3.08 + 0.32 1.27 t 0.25 2.45 + 0.31
3.
Tumors were induced by urethan treatment or virus transfers from
different tissues of infected mice.
^Mean and standard deviation determined for at three experiments.
Activity expressed as micromoles product per minute per milliliter.
Fig. 2. The heat inactivation rate curve of alkaline
phosphatase utilizing para-nitrophenyl phosphate
and cysteamine-S-phosphate as substrate.
o
{nVelocity(jjMp-nitrophenol/min/ml)^ I o-
Table 5. Heat Inactivation of Alkaline Phosphatase Activities Utilizing Two
Different Substrates
Activity^ Percent Inactivation^
Time pNPP GASP pNPP GASP
0 minutes 3.22 + 1.07 1.0 t 0.29
2 minutes. 2.05 + 0.73 0.42 ± 0.21 31.16 t 26.5 57.52 ± 16.16
4 minutes 1.10 + 0.38 0.20 t 0.15 63.76 + 13.51 81.92 t 12.33
6 minutes 0.59 f 0.25 0.12 + 0.13 80.4 + 10.42 88.98 + 12.94
8 minutes 0.27 + 0.19 0.0 90.03 + 6.22 100
10 minutes 0.20 + 0.13 0.0 94.63 + 3.44 100
^Mean and standard deviation determined for at least three experiments.
Activity expressed as micromoles product per minute per milliliters.
^The activity assayed for the incubation time periods was divided by the control
(0 minutes incubation). All tubes except for the control were incubated in a 55 G
water bath.
Fig. 3. Kinetic studies of alkaline phosphatase utilizing







Velocity for pNPP was 1.45 X 10“3 moles ml“^ min~^ and
4.09 X 10“^ moles ml"^ min“^ for CASP.
Table 6 shows APase activity during different stages of
purification of placenta and lymphoma tissue. These data
indicate that even though the total amount of protein was re¬
duced in each step of purification, the ratio of pNPP to CASP
hydrolysis remained approximately the same.










1.28 + 0.25 0.34 + 0.05 3.84 t 1.40
Placenta
75K ppt




2.82 t 0.22 0.88 t 0.15 3.27 t 0.82
Placenta-Lymphoma
0.5M KCl
0.11 t .007 0.04 ± .005 2.55 ± 0.18
Placenta DEAE
0.2M KCl
0.09 t .008 0.03 t .002 2.53 t 0.09
^Different tissues at various levels of purification.
■L
“Mean and standard deviation for at least three experiments.
Activity expressed as micromoles product per minute per milliliters.
CHAPTER V
DISCUSSION
The association of alkaline phosphatase (APase) with
murine lymphoma has been well established. In an effort to
determine the function of APase biochemical characterization
of the hydrolysis of the substrates pNPP and CASP by APase
was performed. APase activity was assayed in extracts taken
from lymphomaceous tissue and placental tissue of normal
sixteen day pregnant C57BL mice.
We found that in crude lymphoma tissue, APase hydrolyzed
pNPP approximately three times that of CASP hydrolysis.
There was no significant difference in the substrate ratios
between different tumors, pNPP and CASP were split at equal
rates by APase isolated from Escherichia coli (Neumann,
1968, 1969). In 1971 Neumann et al. noted that in all murine
leukemia tissue homogenates, the ratio of the hydrolysis rate
of pNPP to the rate of CASP hydrolysis was found to be
greater than the ratio for nonleukemic tissue homogenate.
Moran et al. (1973) and Neumann et al. (1974) isolated an
APase which they named phosphatase N (N-APase). This enzyme
which was extracted from murines and humans inflicted with
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lytnphoproliferative diseases catalyzed the hydrolysis of
monoesters of ortho-phosphoric acid but failed to split the
S-substituted monoester of thio-phosphoric acid, N-APase was
not detected in normal lymphocytes and mitogen induced blast
cells. This unique capacity to differentiate between oxygen
and sulfur linkages between the alcohol moiety and the phos-
phoryl group could suggest that the enzymatic mechanism of
phosphatase N is different from that of the APase in our study.
According to Neumann et al. (1976) the ratio of hydroly¬
sis pNPP/CASP was found to vary between 1.1 and 1.9 for APase
extracted from the thymus, spleen, kidney, and liver tissue
of nonleukemic C57BL/6. This same ratio applied for APase'
present in normal human serum, i.e. pNPP and GASP were hy¬
drolyzed with a similar efficiency. The close analogy between
the reaction of pNPP and GASP with APase isolated from non-
lymphoproliferative cells or serum could be interpreted that
the enzyme does not interact directly with the linking oxygen
or sulfur in a rate determining step. (Neumann et al,, 1976).
Since sulfur and oxygen have different Van der Waals radii,
polarizabilities, and basicities in these substrates, any
interaction with them either in binding or in catalysis would
be expected to give major differences in the catalytic hy¬
drolysis. The lack of such differences distinguishes the
APase extracted from normal murine, normal human, and E. coli
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cells from phosphatase N. This factor is of great importance
when analyzing the mechanism of all APase action.
In our studies the substrate ratios did not vary sig¬
nificantly from normal placental to lymphoma tissue taken
from C57BL mice. pNPP was always hydrolyzed on the average,
approximately 2.7 times GASP hydrolysis whether the tissue
was normal or leukemic. In contrast to the report of Neumann
et al. (1971), APase extracted from murine lymphoma tissue
did hydrolyze GASP. The discrepancy between our data and
Neumann et al., (1970, 1971, 1974, 1976) is not yet fully
understood. The appearance of an enzyme with distinct cata¬
lytic properties may be the result of conformational changes
or a different assembly of subunits through dissociation-
association, allosteric effects, or a change in the metal
ions. The presence of more than one type of APase in the
murine system would be a possibility difficult to comprehend
since the G57BL strain of mice was used for both this study
and that by Neumann et al. (1970, 1971, 1974, 1976).
We also employed the same assay methods. (Neumann pro¬
vided the GASP substrate.) The presence or absence of unknown
cofactors interfering with the measured activity is a factor
to be taken under consideration for both studies.
The hydrolysis of pNPP and GASP employing 1.0 M DEA plus
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5.0 mM magnesium was found to be pH dependent. The assays
were performed on lymphoma enzyme extracts. The APase activ¬
ity approximately doubled when the buffer was changed from a
0.1 M to 1.0 M DEA for both substrates. The pH optimum for
both substrates was 10.0. This pH optimum is in agreement
with Floyd (1976).
They reported an optimal pH of 10.0 using pNPP as sub¬
strate for spleen, lymphoma, placenta, embryo, and embryonic,
thymic, murine tissue. Lumb and Doell (1970) reported no sig¬
nificant difference in pH optimum among murine tumors induced
by different carcinogenic agents.
For the SJL/J, AKR, and C57BL strain of mice, Neumann et
al. (1971) obtained an optimal pH of 9.5 for thymus, spleen,
liver, and kidney, murine tissue. The substrate employed was
pNPP. The buffer used was Tris-HCL and sodium barbital. This
pH optimum did not change significantly between leukemic and
normal tissue. They found that in the thymus the rate of pNPP
hydrolysis remained constant from 9.5-10.4 pH. We found an
approximate 367. increment in APase activity when the pH was
changed from 8.0 to 9.0 and a 757. increment from pH 9.0 to
10.0 using lymphoma tissue. However, the APase activity
dropped approximately 697. when the pH of the buffer was
changed from 10.0 to 11.0.
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The variation in pH optimum of our data and that of
Neumann et al. (1971) could be due to the difference in buf¬
fers employed. The pK* of Tris and DEA is 8.1 and 8.9
respectively.
Using substrates pNPP and GASP, APase extracted from
crude, normal placenta and crude, lymphoma tissue was acti¬
vated by magnesium by approximately the same rate. These
findings are in agreement with Floyd (1976) who also included
the spleen, embryonic thymus and whole embryo in her studies.
Neumann et al. (1971) studied the dependence of APase
activity on magnesium by varying the magnesium concentration
in the reaction mixtures from 10“^ M to 6.0 X 10“^ M. APase
activity expressed as the activity with a variable divided by
the activity without a variable reached a highest level of
1.8 at a concentration of 10“^ M magnesium. When the magnes-
ium concentration was increased from 3 X 10”-^ M to 6 X 10 M
the activation of APase decreased. We found APase activation
by an approximate average factor of 1.8 using substrates pNPP
and GASP and lymphoma and placental tissue. The concentration
of the magnesium added to the enzyme assay was 5.0 X 10"3 m.
At this concentration APase activity dropped below 1.8 according
to Neumann et al. (1971) results. They interpreted a 1.8 ratio
of magnesium activation to be insignificant, so magnesium was
35
excluded from all their reaction mixtures. However, this acti¬
vation was considered significant in our research so magnesium
was included in most of our enzyme assays.
In lymphoma tissue APase was inhibited by an average of
787o by L-homoarginine for both substrates pNPP and GASP.
Kellen and Lustig (1971) studied the patterns of amino acid
inhibition of APase present in human tumor tissue, body fluid,
and serum. They found that the inhibition of APase by L-homo¬
arginine was uncompetitive and stereo-specific.
During the analysis of EDTA inhibition, there was a prob¬
lem with activation occurring in some instances and inhibition
in others. In order to solve this problem I used the assay
method employed by Bramley (1975). He found that pre-incuba¬
tion of mouse ovarian APase in the presence of EDTA and glycine
at an alkaline pH resulted in inactivation of APase activity.
We obtained an average 537o inhibition using both substrates
pNPP and GASP. Inactivation did not occur upon pre-incubation
with EDTA or glycine alone.
It has been generally accepted (Neumann, 1969) that the
catalytic action of APase involves at least two intermediate
complexes; the Michaelis complex, ES and the phosphorylated
enzyme, EP. The rate of alcohol formation: cysteamine from
GASP and pNP from pNPP, gives the rate of the overall reaction.
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A Michaelis constant of 5.0 X 10”^ M pNPP and 1 X 10"^ M
GASP was determined graphically. The maximal velocity for
pNPP was 1.45 X 10“^ moles ml~^ min”^ and 4.09 X 10 ^ moles
ml”^ min"^ for GASP. These values are in agreement with
Prioleau and Lumb (1976). Using the substrate pNPP they ob¬
tained a Bin value of 4.45 X 10“^ M.
Neumann et al. (1967, 1968) determined the Vmax and Km
values for pNPP and GASP under the same conditions utilizing
APase from the coli system. An 0.02 M concentration of
Veronel buffer containing 1.5 M NaGl at a pH of 9.0 was used.
Their concentration of substrate varied between 3 X 10“-^ M
and 3 X 10~2 m for pNPP and a molar variation between
4.0 X 10"^ M and 3 X 10"^ M for GASP. When using the GASP, a
Michaelis constant (Km) of 2.5 X 10”^ M and a maximum rate of
hydrolysis (Vmax) of 0.7 X 10“^ M of substrate ml~^ min“^ was
determined. The Vmax of pNPP was approximately 1.4 times
that for GASP, but the Km value for both the substrates was
essentially the same.
Using APase extracted from ^ coli, Neumann et al. (1967)
determined that GASP competitively inhibits the hydrolysis of
pNPP. They also determined that inorganic phosphate and
phosphorothioate competitively inhibit the enzymic hydrolysis
of GASP and pNPP. Due to this competitive inhibition, they
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suggested that GASP and pNPP bind to the same catalytic site
on APase.
As shown by the various biochemical parameters (pH,
kinetics, activation, etc.) the mode of binding, reaction
mechanism and functional groups appeared to be similar in the
hydrolysis of either the oxygen or sulfur linked substrates.
This similarity in hydrolysis of GASP and pNPP could suggest
that the same site of the enzyme binds both substrates and
that the mechanism of the enzymic hydrolysis of S-P bonds
corresponds to the 0-P bond. Therefore, if both substrates
were utilized in an enzymic reaction, compounds containing a
S-P bond would be expected to compete with compounds contain¬
ing an 0-P bond for a common site. The only apparent differ¬
ences between the action of APase on the two substrates has
been demonstrated to be the rates of hydrolysis.
By biochemical characterization of the APase of the
normal 16-day embryo thymus, it was demonstrated to be the
same as the APase extracted from the tumor and normal spleen
(Lumb and Doell, 1970). In this study, enzyme assays were
performed on pooled extracts taken from lymphoraaceous tissue
of the spleen, thymus, and lymph nodes.
APase was solubilized from sedimented membranes with
Noniodet P-40 detergent. At this level of purification the
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APase activity did not vary significantly from the activity
present in the crude extract. This solubilized enzyme was
then treated with butanol and then further purified by ion
exchange chromatography using DEAE cellulose. The first
fraction was eluted by a low salt concentration (0.2 M KCl) .
The second fraction was eluted by a higher salt concentra¬
tion (0.5 M KCl). According to the students t-test the ratio
of pNPP hydrolysis to GASP hydrolysis did not vary signifi¬
cantly throughout the levels of purification. This consis¬
tent substrate ratio is indicative of the isolation of one
enzyme.
Neumann et al. (1976) purified an APase, which they
named N-APase, from an human lymphoblastoid cell line (Daudi)
and Moloney-virus-induced murine leukemia cells (YAC). N-APase
has demonstrated several properties unique to the APase iso¬
lated in our study. Both enzymes demonstrated a high affinity
for ion exchange materials. Neumann et al. (1976) added 5.0
milligrams of poly(L-lysine) to the homogenate for separation
of the highly negatively charged compounds. After applying
>
to a DEAE-cellulose column, 0.5 M amino ethanol buffer
instead of KCl which we used, was employed to elute the N-APase
from the column. Following centrifugation, Neumann et al.
(1976) concentrated the eluates with Aquacid and then reapplied
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the enzyme extract to Sephadex G-200 or Sepharose 4B columns
for further purification. APase activity was measured using
pNPP and GASP as substrates. However, GASP failed to be hydro¬
lyzed which was a different characterization from the APase
purified in our studies. They achieved a 100 to 1,000 fold
purification with one protein band following polyacrylamide
gel electrophoresis.
Neumann et al. (1976) observed that N-APase only appeared
in the instance of lymphoproliferative disorders, murine
lymphoma cells, lymphoblastoid cell lines and leukemias. How¬
ever, N-APase was not located in normal lymphocytes and
mitogen-induced blast cells. These results distinguished
cells of a lymphoid origin from which one could suggest that
the appearance of N-APase could be connected with a special
type of blast transformation.
The function of APase is still unknown. The membrane
location of APase has been well substantiated. This enzyme
appears at a high level in tissue where considerable active
transport is involved, such as the placenta. This could sug¬
gest that APase plays a role in active transport. In this
study APase has been demonstrated to split the phosphate off
of GASP and pNPP. In previous studies in this laboratory
(Moore, 1975), APase hydrolyzed the high energy compound ATP.
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Since active transport does take place in the membrane by
splitting phosphates APase could provide the energy necessary
for active transport. The high level of APase in tissue that
is conducting cell proliferation could be accounted for if
APase functions in the active transport of nutrients. The
enzyme would in this instance be providing the raw materials
necessary for cell proliferation. A better insight into the
possible role of APase could be understood if the acceptor
of the hydrolyzed phosphates could be demonstrated in vivo.
CHAPTER VI
SUMMARY
For this study, APase was isolated from crude extracts
of lymphomateous thymus, spleen, and lymph nodes, and crude
extracts of the placenta from sixteen day pregnant C57BL
mice. Since crude extracts were employed for the bulk of
this study, several biochemical parameters were performed to
ascertain the absence of any APase isozymes. The parameters
utilized were pH optimum, magnesium activation, L-homoarginine
and EDTA inhibition, substrate specificity, heat inactivation,
enzyme kinetics, and purification.
Enzyme assays revealed that optimal APase activity was
dependent upon the pH and magnesium concentration of the DEA
buffer employed. Utilizing substrates pNPP and GASP, the
optimal pH was 10.0. APase activity was activated by magnesium
by approximately the same rate for both substrates. No sig¬
nificant differences between the substrates pNPP and CASP
could be distinguished when analyzing the inhibitory effects
of APase activity caused by L-homoarginine or EDTA. An en¬
hanced thermal instability of APase was achieved when CASP was
utilized as a substrate since at the end of eight minutes in¬
cubation at 55 degrees centigrade the heat inactivation was
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complete. Total inactivation was never obtained when pNPP
was used as a substrate after a ten minute incubation period
at 55 degrees centigrade. According to the slopes obtained,
the actual rates of inactivation did not vary significantly
between the two substrates. No significant difference was ob¬
tained for the Km values determined by pNPP or GASP hydrolysis
by APase. It was determined that only one APase enzyme was
isolated since the ratio of pNPP to GASP hydrolysis remained
approximately the same throughout the levels of purification.
The most significant difference in APase activity between
the substrates pNPP and GASP was the rate of hydrolysis.
Throughout all of the biochemical parameters employed pNPP
hydrolysis was approximately three times the hydrolysis of
GASP. These results are contradictory to those obtained by
Neumann et al., 1974. They found that APase extracted from
the thymic lymphoma of G57BL mice did not hydrolyze GASP while
it did hydrolyze pNPP. We found GASP activity using this same
strain of mice inflicted with thymic lymphoma. The reason for
this discrepancy in results is presently unknown.
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